Pfizer Stock News

SEOUL South Korea has approved Pfizers COVID-19 vaccine for use with children aged 5-11, the countrys food and drug ministry said on Wednesday. Children should get one-third of the regular dose, twice with a three week interval, the ministry said in a statement. Children with significantly declined immunity can get a booster four weeks []

Pfizer will halt a controversial practice of cutting discounts on Enbrel to Dutch hospitals that started ordering less of the drug.

GlaxoSmithKline(GSK) announced that its consumer healthcare division partly owned by Pfizer (PFE) would be called Haleon after its spinoff from the main business. Read more.

South Africans don''t even know where their government is actually buying vaccines, says the Health Justice Initiative.

The Conjugate Vaccine Market research report provides an in-depth overview of the industry including market segmentation by product, technology, vertical and geography. Analysis of the global market with special focus on high growth application in each vertical and fast-growing application

UK Prime Minister Sets Out Plan For Living With COVID Reading Time: 5 minutes The Prime Minister sets out the Governments plans to live with and manage the virus. Vaccines will remain the first line of defence against Covid-19 as the Prime Minister sets out the Governments plans to live with and manage the virus. The UK was the first country in the world to authorize the use of the Pfizer Read More

Vaccines will remain the first line of defence against Covid-19 as the Prime Minister sets out the Governments plans to live with and manage the virus. The UK was the first country in the world to authorise the use of the Pfizer and Oxford-AstraZeneca vaccines, the first European country to vaccinate 50% of its population and has delivered the fastest booster programme in Europe.

The Scottish unit of French vaccine maker Valneva has received a grant of up to 20 million pounds ($27 million) to partly fund the research and development (R&D) of manufacturing its COVID-19 vaccine VLA2001, the company said on Monday. Valneva will receive the funds from Scotland''s national economic development agency Scottish Enterprise, which it has been in talks with since December. The funding will come in two tranches. The first grant of up to 12.5 million pounds will support the company''s efforts on the VLA2001, its inactivated, whole virus COVID-19 vaccine candidate. The second round of up to 7.5 million pounds will be used for Valneva''s other vaccines. Apart from the highly awaited COVID-19 vaccine, Valneva is developing VLA1553, a mosquito-born viral infection chikungunya vaccine, which it intends to produce in the Scottish town of Livingston, near Edinburgh. It has recently reported positive phase 3 data for both VLA2001 and VLA1553. 4.7m doses of Pfizer vaccine arrive "Valneva is a valued contributor to our life sciences sector and the Livingston facility

The unvaccinated who can land a dose of J&J still have the advantage over those with a single dose of Pfizer, though by 51 days

Vaccine sites have been told to honour a preference for a J&J booster after a Pfizer course, or the other way around, but there may be practical trouble.

Experts are predicting demand for life-saving antiviral drugs will rapidly outpace supply. Like the vaccine, the poorest countries will be left until last Covid-19 has quietly become the gift that keeps on giving for big pharma. The past two years has seen it reap huge profits from Covid vaccines, while simultaneously opposing wider sharing of the technology required to make them. And now theres a new money-spinner on the rise: Covid antiviral treatment pills. Once again, were poised to fall into the same inequality traps were caught in with the global vaccine rollout. Both Pfizer and Merck have new antiviral pills rapidly arriving on the market Paxlovid and molnupiravir respectively. As with the vaccines that came before them, both corporations have made it their business to ultimately decide who gets to make generic versions through the medical patent system a crucial, life-saving question for millions around the world. Othoman Mellouk is a medicine access advocate with the International Treatment Preparedness Coalition Continue reading.

FDA Weighs Authorizing Second COVID Booster Jab Despite repeated warnings from the WHO that emerging nations should be given priority access to the mRNA vaccines produced by Moderna and Pfizer, American authorities are looking at potentially authorizing a second doses for at least some patients as they further consider whether to recommend annual boosters. The planning is still in its early stages, and authorization would ultimately depend on ongoing studies establishing that a fourth dose would shore up people''s molecular defenses, which have waned after their first booster and reduced their risk of symptomatic and severe disease. Among the issues that need to be resolved, according to WSJ''s source, are whether the second booster dose should be authorized for all adults or particular age groups, and whether it should target the omicron variant specifically, or be formulated differently. Whether the fourth booster could ultimately be the start of annual COVID vaccinations is also under consideration; no decision is final, and it could be necessary to make booster shots available earlier if a more dangerous, elusive variant were to emerge.

U.S. health regulators are looking at authorizing a potential fourth dose of a COVID-19 vaccine in the fall, the Wall Street Journal reported on Saturday, citing sources familiar with the Read more » The post Report: FDA Considers Approving Second COVID-19 Booster Shot appeared first on Hamodia . In related news: Trump Unveils Three-Stage Process for States to End Coronavirus Shutdown U.S., European COVID Vaccine Developers Pledge to Uphold Testing Rigor California Businesses Go From Simmer to Boil Over Newsoms Fine Dining U.S. Vaccine Drive Complicated by 1st, 2nd Dose Juggling Act FDA Advisers Back Pfizers COVID-19 Vaccine for Young Kids

Pathologists who examined the autopsies of two teenage boys who died days after receiving Pfizers COVID-19 vaccine concluded the vaccine caused the teens deaths. The three pathologists, two of whom are medical examiners, published their findings Feb. 14 in an early online release article, Autopsy Histopathologic Cardiac Findings in Two Adolescents Following the Second COVID-19 The post Pathologists reveal how two teenagers were killed by Pfizers COVID vaccine appeared first on National Daily Newspaper .